Hydroflumethiazide

Phosphocreatine: Phosphocreatine , nke a makwaara dị ka creatine phosphate ( CP ) ma ọ bụ PCr ( Pcr ), bụ phosphorylated creatine molecule nke na-arụ ọrụ dị ka ihe nchekwa ngwa ngwa nke ike phosphates dị ike na akwara skeletal, myocardium na ụbụrụ iji weghachite adenosine triphosphate, ego ike nke ụlọnga
Fructose 1,6-bisphosphate: Fructose 1,6-bisphosphate , nke a makwaara dị ka Harden-Young ester , bụ fructose sugar phosphorylated na carbons 1 na 6. β- D -form nke ogige a bụ ihe dị na mkpụrụ ndụ. Mgbe ha banyere n'ime sel ahụ, ọtụtụ glucose na fructose na-agbanwe fructose 1,6-bisphosphate.
Coenzyme Q10: Coenzyme Q , nke a makwaara dị ka ubiquinone , bụ ezinụlọ coenzyme nke jupụtara ebe niile na ụmụ anụmanụ na ọtụtụ nje bacteria (yabụ aha ubiquinone). N'ime ụmụ mmadụ, ụdị kachasị dịkarịsịrị bụ coenzyme Q 10 ma ọ bụ ubiquinone-10 . Ndị US Food and Drug Administration (FDA) anabataghị CoQ 10 maka ọgwụgwọ nke ọnọdụ ahụike ọ bụla; agbanyeghị, a na-ere ya dị ka mgbakwunye nri yana ihe mgwa na ụfọdụ ntecha.
Adenosine: Adenosine bu ihe ndi ozo nke na eme otutu ihe ndi ozo di iche iche. Molekul ahụ nwere ihe adenine nke metụtara na ribose site na β-N 9 -glycosidic bond. Adenosine bụ otu n'ime ngọngọ nrụpụta anọ dị n'ime DNA na RNA, nke dị mkpa maka ndụ niile. Ihe ndi ozo gunyere ndi n'eme ike bu adenosine mono-, di-, na triphosphate, nke a makwaara dika AMP / ADP / ATP.
Tiracizine: Tiracizine bụ ihe na- egbochi antiarrhythmic.
Acadesine: Acadesine (INN), nke a makwaara dị ka 5-aminoimidazole-4-carboxamide-1-β- D -ribofuranoside , AICA-riboside , na AICAR , bụ ihe eji arụ ọrụ protein kinase activator AMP nke ejiri maka ọgwụgwọ nnukwu ọrịa leukemia lymphoblastic na nwere ike itinye akwụkwọ n'ịgwọ nsogbu ndị ọzọ dịka ọrịa shuga.
Trimetazidine: Trimetazidine bụ ọgwụ maka angina pectoris rere n'okpuru ọtụtụ aha njirimara. A kọwara Trimetazidine dị ka onye ọrụ cytoprotective mgbochi ischemic nke ụlọ ọrụ Laboratoires Servier (France) zụlitere ma ree ya. Trimetazidine bụ ọgwụ mgbochi ischemic (anti-anginal) nke metabolic nke klaasị acid oxidation klaasị, nke pụtara na ọ na-eme ka myocardial glucose tinye n'ọrụ site na mgbochi nke abụba acid metabolism.
Ibuprofen: Ibuprofen bụ ọgwụ na klas na-adịghị egbochi ọgwụ ọjọọ (NSAID) nke a na-eji maka ịgwọ mgbu, ahụ ọkụ, na mbufụt. Nke a na-agụnye oge mgbu nke ịhụ nsọ, mpụga, na ọrịa ogbu na nkwonkwo. Enwere ike iji ya mechie patent ductus arteriosus na nwa akaghi aka. Enwere ike iji ya jiri ọnụ ma ọ bụ intravenously. Ọ na - amalite ịrụ ọrụ n'ime otu awa.
Ivabradine: A na- ere Ivabradine , nke a na-ere n'okpuru akara aha Procoralan n'etiti ndị ọzọ, bụ ọgwụ eji eme ihe maka njikwa mgbaàmà nke obi mgbu obi metụtara obi na nkụda mmụọ nke ndị na-egbochi beta anaghị achịkwa.
Ranolazine: Ranolazine , nke e rere n'okpuru akara aha Ranexa n'etiti ndị ọzọ, bụ ọgwụ eji agwọ ọrịa obi metụtara obi. A na-ejikarị ya na ọgwụ ndị ọzọ mgbe ndị ahụ ezughi oke. Uru dị iche iche bara uru karịa ụmụ nwanyị karịa ụmụ nwoke. A na-eji ọnụ ewere ya.
Icatibant: Icatibant , nke e rere n'okpuru aha aha Firazyr , bụ ọgwụ maka ọgwụgwọ nke mgbaàmà nke nnukwu ọgụ nke ọrịa angioedema (HAE) na ndị okenye nwere ụkọ C1-esterase-inhibitor. Ọ naghị adaba na ọrịa angioedema nke ọgwụ sitere n'aka klaasị ACE.
Regadenoson: Regadenoson , nke e rere n'okpuru akara aha Lexiscan n'etiti ndị ọzọ, bụ agonist nnabata adenosine nke AA bụ 2A nke bụ nkwonkwo akwara nke a na-ejikarị na ule nrụgide ọgwụ. Ọ na-emepụta hyperemia ngwa ngwa ma na-echekwa ya ruo ogologo oge nke bara uru maka ima ihe na-esi ísì ụtọ nke radionuclide myocardial. Ọdịdị nhọrọ nke ọgwụ ahụ na-eme ka ndị ọrụ nrụgide ndị ọzọ dị mma dị ka adenosine, bụ ndị na-anaghị ahọ nhọrọ ma ya mere na-akpata mmetụta ndị ọzọ.
ATC code C01: Usoro ATC C01 Cardiac bụ ngalaba ọgwụgwọ nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka ịkekọrịta ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C01 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Rescinnamine: Rescinnamine , nke ejiri ụdị aha a na-akpọ moderil , cinnasil , na anaprel , bụ ọgwụ enzyme na-agbanwe angiotensin nke a na-eji dị ka ọgwụ na- emegide ọbara ike.
Reserpine: Reserpine bụ ọgwụ a na-eji maka ọgwụgwọ ọbara mgbali elu, na-ejikọkarị ya na thiazide diuretic ma ọ bụ vasodilator. Nnukwu ule siri ike egosila na ọgwụgwọ agwakọtara na reserpine tinyere thiazide diuretic na-ebelata ọnwụ nke ndị nwere ọbara mgbali elu. Ọ bụ ezie na ojiji nke Respine dị ka a solo ọgwụ jụrụ ebe ọ bụ na ọ na-akpa mma site FDA na 1955, a nyochaa na-atụ aro iji Respine na a thiazide diuretic ma ọ bụ vasodilator na ọrịa ndị na-adịghị enweta zuru ezu agbada ọbara mgbali na mbụ-akara ọgwụ ọgwụgwọ naanị. Respine-hydrochlorothiazide combo pill bụ nke 17th a na-enyekarị iwu nke ọgwụ 43 na-egbochi ọgwụ mgbochi ọbara dị na 2012.
Deserpidine: Deserpidine (INN) bụ ọgwụ na- emegide ọbara ọbara metụtara ọgwụ na-apụta n'ụzọ nkịtị na Rauvolfia spp.
Methoserpidine: Methoserpidine bụ ọgwụ antihypertensive metụtara reserpine.
Bietaserpine: Bietaserpine (INN), ma ọ bụ 1-diaminoethylreserpine , bụ ihe na- ewepụta ndapụta mmiri nke ejiri mee ihe dị ka onye na-egbochi ọgwụ mgbochi. Dị ka reserpine, bietaserpine bụ ihe mgbochi VMAT.
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Methyldopa: Methyldopa , nke e rere n'okpuru akara aha Aldomet na ndị ọzọ, bụ ọgwụ eji eji ọbara mgbali elu. Ọ bụ otu n'ime ọgwụgwọ kachasị mma maka ọbara mgbali elu na afọ ime. Maka ụdị ọbara mgbali elu ndị ọzọ gụnyere ọbara mgbali elu dị elu nke na-akpata mgbaàmà ọgwụ ndị ọzọ na-ahọrọkarị. Enwere ike inye ya site na onu ma obu ogwu ogwu. Mbido nke mmetụta dị ihe dị ka awa 5 ma ha dị ihe dị ka otu ụbọchị.
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Clonidine: Clonidine , nke a na-ere dị ka aha a na-akpọ Catapres n'etiti ndị ọzọ, bụ ọgwụ eji agwọ ọbara mgbali elu, ọrịa mgbochi ọrịa mwepụ, ị withdrawalụ ọgwụ ọjọọ, menopausal flushing, afọ ọsịsa, spasticity na ụfọdụ ọnọdụ mgbu. A na-eji ya ọnụ, na ogwu ogbugba, ma ọ bụ dị ka ihe nkedo akpụkpọ. Mmalite nke ihe a na - ahụkarị n'ime otu elekere na - enwe mmetụta na ọbara mgbali na - adịgide ruo elekere asatọ.
Guanfacine: Guanfacine , nke a na-ere n'okpuru akara aha Tenex n'etiti ndị ọzọ, bụ ọgwụ a na-edeghị ede iji gwọọ ọrịa mgbochi ọrịa (ADHD) na ọbara mgbali elu. A naghị ele ya anya dị ka usoro ọgwụgwọ mbụ maka ngosipụta abụọ.
Tolonidine: Tolonidine bụ antihypertensive.
Moxonidine: Moxonidine (INN) bu ohuru alpha-2 / imidazoline nke na-anabata agonist antihypertensive ọgwụ enyere ikikere maka ogwugwo nke obula di nkpa. Ọ nwere ike ịnwe ọrụ mgbe thiazides, beta-blockers, ACE inhibitors, na calcium channelers blockers anaghị adabara ma ọ bụ ghara ịchịkwa ọbara mgbali. Tụkwasị na nke a, ọ na-egosipụta mmetụta dị mma na oke nke ọrịa insulin resistance, o doro anya na ọ nwere onwe ya na mbelata ọbara mgbali. Ọ bụkwa uto hormone releaser. Ọ bụ Solvay Pharmaceuticals na-emepụta ya n'okpuru akara aha ya bụ Physiotens & Moxon.
Rilmenidine: Rilmenidine bụ ọgwụ ndenye ọgwụ maka ọgwụgwọ ọbara mgbali elu. A na-ere ya n'okpuru aha ndị a na-akpọ Albarel , Hyperium , Iterium na Tenaxum .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Trimetaphan camsilate: Trimetaphan camsilate (INN) ma ọ bụ trimethaphan camsylate (USAN), aha ahia bụ Arfonad , bụ ọgwụ na-egbochi nnyefe cholinergic na ụdị ganglion nke ndị na-anabata nicotinic nke ganglia autonomic ma ya mere na-egbochi ma usoro ọmịiko ọmịiko na usoro ụjọ ahụ ọmịiko. Ọ na - eme dịka onye na - emegide asọmpi na - enweghị ọgwụ na acetylcholine nicotinic, na - adị mkpụmkpụ, ma nye ya nsị.
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Mecamylamine: Mecamylamine bụ onye na-abụghị nhọrọ, onye na-abụghị onye na-asọ mpi nke ndị nabatara acetylcholine nicotinic (nAChRs) nke ewepụtara na 1950s dị ka ọgwụ mgbochi mgbatị. Na United States, ejiri aka ya wepụrụ ya n'ahịa ahụ na 2009 mana ewebatara ya n'ahịa na 2013 dị ka Vecamyl ma mechaa ree Turing Pharmaceuticals.
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Prazosin: Prazosin bụ ọgwụ alpha-1 na-ejikarị agwọ ọbara mgbali elu, mgbaàmà nke prostate gbasaa, na nsogbu nrụgide posttraumatic (PTSD). Ọ bụ ọgwụgwọ na-adịchaghị mma nke ọbara mgbali elu. Ihe ndị ọzọ nwere ike ịgụnye nkụda obi na ọrịa Raynaud. A na-eji ọnụ ewere ya.
Indoramin: Indoramin bụ piperidine antiadrenergic n'ụlọnga.
Trimazosin: Trimazosin bụ onye na-egbochi mkpụrụedemede nwere ọmịiko.
Doxazosin: Doxazosin , nke e rere n'okpuru akara aha Cardura na ndị ọzọ, bụ ọgwụ eji agwọ ọrịa nke ọrịa hyperplasia na-arịa ọrịa ọbara na ọbara mgbali elu. Maka ọbara mgbali elu, ọ bụ nhọrọ kachasị mma. A na-eji ọnụ ewere ya.
Urapidil: Urapidil bụ ọgwụ ọmịiko na-enye ọmịiko. Ọ na - eme dịka ant 1 -adrenoceptor antagonist yana 5-HT 1A agonist na - anabata ya . Ọ bụ ezie na akụkọ mbụ gosipụtara na urapidil bụkwa ag 2 -adrenoceptor agonist, nke a emeghị ka ọ pụta ìhè n'ọmụmụ ihe mechara gosipụta na ọ nweghị usoro agonist na akwara saphenous dog na Guinea-Guinea ileum. N'adịghị ka ụfọdụ ndị ọzọ na-emegide α 1 -adrenoceptor antagonists, urapidil anaghị egosipụta tachycardia reflex, na nke a nwere ike ịdị na arụmọrụ ya na-adịghị ike β 1 -adrenoceptor antagonist, yana mmetụta ya na obi vagal drive. Urapidil anaghị anabata ya ugbu a Nchịkwa nri na ọgwụ ọjọọ na US, mana ọ dị na Europe.
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Bethanidine: Bethanidine bụ ọgwụ ọmịiko.
Guanethidine: Guanethidine bụ ọgwụ na- emegide ọbara mgbali nke na-ebelata ịhapụ catecholamines, dịka norepinephrine. A na-ebuga Guanethidine gafee akpụkpọ ahụ nwere ọmịiko site na otu usoro ahụ na-ebugharị norepinephrine n'onwe ya, na ibute ihe dị mkpa maka ọrụ ọgwụ ahụ. Ozugbo guanethidine abanyela akwara, ọ na-etinye uche na transmitter vesicles, ebe ọ na-anọchi norepinephrine. O nwekwara ike igbochi ịhapụ granulu site na ibelata norepinephrine.
Guanoxan: Guanoxan bụ ọgwụ ọmịiko e rere dị ka Envacar nke Pfizer na UK iji gwọọ ọbara mgbali elu. Ejighi ya eme ihe ma emesia wepụrụ ya n'ahịa n'ihi ọrịa imeju.
Debrisoquine: Debrisoquine bụ ihe na-emepụta guanidine. O bu ogwu antihypertensive dika guanethidine. A na-ejikarị Debrisoquine eme ihe maka phenotyping the CYP2D6 enzyme, ọgwụ na-etinye ọgwụ enzyme.
Guanoclor: Guanoclor (INN), nke a makwaara dị ka guanochlor , bụ ọgwụ nwere ọmịiko. A maara ya ka ọ ghara ijikọ saịtị ndị na-abụghị adrenergic na membranes.
Guanazodine: Guanazodine bụ ọgwụ nwere ọmịiko na-enye ume.
Guanoxabenz: Guanoxabenz bụ metabolite nke guanabenz.
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Diazoxide: Diazoxide , nke a na-ere n'okpuru akara aha Proglycem na Balila (India) , bụ ọgwụ eji agwọ shuga dị ala n'ihi ọtụtụ ihe kpatara ya. Nke a na-agụnye etuto cell nke na-enweghị ike iwepụ na mmetụta nke leucine. A pụkwara iji ya mee ihe na-adịghị mma nke nsị nke sulfonylurea. A na-ejikarị ọnụ ewere ya.
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Dihydralazine: Dihydralazine bụ ọgwụ nwere ọgwụ antihypertensive. O bu nke hydrazinophthalazine chemical klas. O nwere mmetụta yiri nke ahụ na hydralazine.
Hydralazine: Hydralazine , nke e rere n'okpuru akara aha Apresoline na ndị ọzọ, bụ ọgwụ eji agwọ ọbara mgbali elu na nkụda mmụọ. Nke a gụnyere ọbara mgbali elu na afọ ime na ọbara mgbali elu dị ukwuu na-ebute ihe mgbaàmà. Achọpụtala na ọ bara uru na nkụda obi, yana isosorbide dinitrate, maka ọgwụgwọ nke ndị Africa. A na-enye ya n'ọnụ ma ọ bụ site na ogwu n'ime akwara. Mmetụta na-amalitekarị na nkeji iri na ise wee ruo elekere isii.
Endralazine: Endralazine bụ antihypertensive nke klaasị hydrazinophthalazine. A kwadoghị ya iji ya na United States.
Cadralazine: Cadralazine bụ antihypertensive nke klaasị hydrazinophthalazine.
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Minoxidil: Minoxidil bụ ọgwụ eji agwọ ọrịa ọbara mgbali elu na ntutu ntutu isi na ụmụ nwoke na nwanyị. Ọ bụ antihypertensive vasodilator. A na-enweta ya dị ka ọgwụ ọgwụ site na ndenye ọgwụ na mpempe akwụkwọ mbadamba ọnụ na n'elu tebụl dị ka mmiri mmiri ma ọ bụ ụfụfụ.
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Sodium nitroprusside: Sodium nitroprusside ( SNP ), nke a na-ere n'okpuru aha a na-akpọ Nitropress n'etiti ndị ọzọ, bụ ọgwụ eji belata ọbara mgbali. Enwere ike ịme ya ma ọ bụrụ na ọbara mgbali elu dị elu ma na-ebute ihe mgbaàmà, n'ụdị ụfọdụ nke nkụda obi, yana n'oge ịwa ahụ iji belata ọbara ọgbụgba. A na-eji ya site na ogwu na-aga n'ihu n'ime akwara. Mbido na-abụkarị ozugbo na mmetụta na-adịgide ruo nkeji iri.
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Pinacidil: Pinacidil bụ ọgwụ cyanoguanidine nke na-emepe ọwa potassium ndị nwere mmetụta nke ATP na-emepụta vasodilatation nke arterioles. Ọ na-ebelata ọbara mgbali na elu na-eguzogide ma na-amịpụta njigide mmiri.
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Veratrum: Veratrum bu genus nke okooko osisi n'ime ezinụlọ Melanthiaceae. Ọ na-eme na ebe obibi mmiri mmiri na-agafe ọtụtụ ọnọdụ ọkụ na subarctic Europe, Asia, na North America.
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Metirosine: Metirosine bụ ọgwụ na-eme ka ọbara mgbali elu . Ọ na - egbochi enzyme tyrosine hydroxylase na, ya mere, njikọ catecholamine, nke, na - arụpụta, na - ebelata ogo nke catecholamines dopamine, adrenaline na noradrenaline na ahụ.
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Pargyline: Pargyline (aha a na-akpọ Eutonyl ) bụ ọgwụ na-eme mgbanwe monoamine oxidase (MAO) -B ọgwụ mgbochi ( IC 50 maka MAO-A bụ 0.01152 μmol / L na MAO-B bụ 0.00820 μmol / L) E wetara ya n'ahịa na US na UK site n'aka Abbott na 1963 dị ka ọgwụ antihypertensive akpọrọ "Eutonyl \". Ọ bụ otu n'ime ọtụtụ ndị na-emechibido MAO nke ewepụtara na 1960 gụnyere nialamide, isocarboxazid, phenelzine, na tranylcypromine. Ka ọ na-erule 2007, a kwụsịrị ọgwụ ahụ yana dịka nke 2014 enweghị ụdị nsụgharị dị na US. Na mgbakwunye na omume ya dị ka MAOI, a chọpụtala pargyline iji njikọ dị elu na ihe nnabata I 2 imidazoline (saịtị allosteric na MAO enzyme).
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Ketanserin: Ketanserin (INN, USAN, BAN) (aha a na-akpọ Sufrexal ; aha koodu mmepe mbụ R41468 ) bụ ọgwụ eji agwọ ọrịa dị ka onye na-egbochi ọgwụ mgbochi na nyocha sayensị iji mụọ usoro serotonin; kpọmkwem, ezinụlọ nnata 5-HT 2 . Achọpụtara ya na Janssen Pharmaceutica na 1980.
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Bosentan: Bosentan , nke a na-ere n'okpuru aha a na-akpọ Tracleer n'etiti ndị ọzọ, bụ ọgwụ na-anabata endothelin nnabata abụọ na-eji agwọ ọrịa ọbara mgbali elu (PAH).
Ambrisentan: Ambrisentan bụ ọgwụ egosiri maka iji ọgwụgwọ ọbara mgbali elu.
Sitaxentan: Sitaxentan sodium (TBC-11251) bụ ọgwụ maka ọgwụgwọ ọbara mgbali elu (PAH). Ejiri ya dị ka Thelin site n'aka Encysive Pharmaceuticals ruo mgbe Pfizer zụrụ Encysive na February 2008. Na 2010, Pfizer jiri aka ya wepu sitaxentan n'ahịa n'ihi nchegbu gbasara nsị imeju.
Macitentan: Macitentan , nke a na-ere n'okpuru aha a na-akpọ Opsumit , bụ onye na-anabata ihe nnabata endothelin (ERA) kwadoro maka ọgwụgwọ ọbara mgbali elu (PAH) Ndị ọzọ ERA ere dị ka nke 2014 bụ bosentan na ambrisentan. Macitentan bụ ERA abụọ, nke pụtara na ọ na-arụ ọrụ dị ka onye na-emegide mmadụ abụọ endothelin (ET) subtypes, ET A na ET B. Agbanyeghị, macitentan nwere nhọrọ ahọta iri ise na-abawanye maka ụdị subịrị ETA ma e jiri ya tụnyere subtype ETB. Ọgwụ sitere na US Food and Drug Administration (FDA) nweta ọgwụ nkwado na October 13, 2013.
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C02: ATC koodu C02 Antihypertensives bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, usoro nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C02 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C03: ATC koodu C03 Diuretics bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, sistemụ nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C03 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C03: ATC koodu C03 Diuretics bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, sistemụ nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C03 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
ATC code C03: ATC koodu C03 Diuretics bụ ngalaba ọgwụ na-agwọ ọrịa nke Anatomical Therapeutic Chemical Classification System, sistemụ nke mkpụrụedemede ọnụọgụ nke World Health Organisation (WHO) mepụtara maka nhazi ọgwụ na ngwaahịa ọgwụ ndị ọzọ. Subgroup C03 bụ akụkụ nke akụkụ anatomical C Cardiovascular system .
Bendroflumethiazide: Bendroflumethiazide , na mbụ bendrofluazide , aha ahia Aprinox , bụ turezide diuretic eji agwọ ọbara mgbali.
Hydroflumethiazide: Hydroflumethiazide bụ mamịrị mamịrị.